Current State of Compassionate Phage Therapy

Area of Science:

• Microbiology
• Infectious Diseases
• Biotechnology

Background:

• Antibiotic resistance poses a significant unmet medical need.
• Phage therapy is being explored as an alternative treatment for infections.
• Compassionate use of phage therapy (cPT) is currently limited.

Purpose of the Study:

• To review existing literature on compassionate phage therapy.
• To discuss available phage sources for compassionate use.
• To explore strategies for expanding access to cPT.

Main Methods:

• Systematic review of published cPT cases.
• Analysis of phage sourcing and production methods.
• Discussion of regulatory and logistical challenges.

Main Results:

• cPT has a history of use with apparent safety and efficacy.
• Limited availability and variable treatment protocols hinder widespread adoption.
• Phage production and purification present scalability challenges.

Conclusions:

• cPT can bridge the gap until new antibiotic treatments are approved.
• Developing guidelines and central coordination can improve cPT accessibility.
• Standardizing cPT processes is crucial for ensuring quality, safety, and therapeutic benefit.